Findings on molecular defects behind bladder cancer may pave way for new, targeted tr
The once sketchy landscape of the molecular defects behind bladder cancer now resembles a road map to new, targeted treatments thanks to the unified efforts of scientists and physicians at 40 institutions.
Linear Mode
